T. Rowe Price discloses 6.5% MOH stake via Schedule 13G
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 3,509,476 shares of Molina Healthcare, Inc. common stock, equal to 6.5% of the class as of 09/30/2025.
The firm reports sole voting power over 3,444,520 shares and sole dispositive power over 3,507,472 shares, with no shared voting or dispositive power. Filed in its capacity as an investment adviser, the statement affirms the holdings were acquired and are held in the ordinary course and not for changing or influencing control.
Positive
- None.
Negative
- None.
FAQ
What stake in MOH did T. Rowe Price report on Schedule 13G?
What voting power did T. Rowe Price disclose for MOH?
What dispositive power did T. Rowe Price report for MOH shares?
What is the event date tied to this MOH ownership disclosure?
Under which form and capacity did T. Rowe Price file?
What is the CUSIP for Molina Healthcare’s common stock?